BioNano Genomics, Inc. (BNGO) Reports Q4 EPS of $0.00

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to BioNano Genomics, Inc. (BNGO) Reports Q4 EPS of $0.00

Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update

March 5, 2020 4:01 PM EST

SAN DIEGO, March 05, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, today reported its financial results for the fourth quarter and year ended December 31, 2019 and provided a business update.

Recent Business Highlights

Announced updates to the Saphyr system designed to increase the speed of data collection, simplify sample preparation for solid tumors and animal tissue, and significantly... More